Cargando…

In Silico Identification of Potential Druggable Binding Sites on CIN85 SH3 Domain

Protein-protein interactions (PPIs) play a pivotal role in the regulation of many physiological processes. The dysfunction of some PPIs interactions led to the alteration of different biological pathways causing various diseases including cancer. In this context, the inhibition of PPIs represents an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vittorio, Serena, Seidel, Thomas, Garon, Arthur, Gitto, Rosaria, Langer, Thierry, De Luca, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825788/ https://www.ncbi.nlm.nih.gov/pubmed/33430321 http://dx.doi.org/10.3390/ijms22020534

Ejemplares similares

Exploring Molecular Contacts of MUC1 at CIN85 Binding Interface to Address Future Drug Design Efforts
por: Gulotta, Maria Rita, et al.
Publicado: (2021)

Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS
por: Havrylov, Serhiy, et al.
Publicado: (2009)

Inhibition of CIN85-Mediated Invasion by a Novel SH3 Domain Binding Motif in the Lysyl Oxidase Propeptide
por: Sato, Seiichi, et al.
Publicado: (2013)

In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules
por: Vittorio, Serena, et al.
Publicado: (2021)

In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets
por: Ricci, Federico, et al.
Publicado: (2022)

CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes
por: Teng, Beina, et al.
Publicado: (2016)

High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site
por: Marlowe, Timothy, et al.
Publicado: (2019)

CIN85 phosphorylation is essential for EGFR ubiquitination and sorting into multivesicular bodies
por: Schroeder, Barbara, et al.
Publicado: (2012)

Complex of MUC1, CIN85 and Cbl in Colon Cancer Progression and Metastasis
por: Cascio, Sandra, et al.
Publicado: (2015)

Germline deletion of CIN85 in humans with X chromosome–linked antibody deficiency
por: Keller, Baerbel, et al.
Publicado: (2018)

Phosphorylation of Human Tristetraprolin in Response to Its Interaction with the Cbl Interacting Protein CIN85
por: Kedar, Vishram P., et al.
Publicado: (2010)

Applications of the Pharmacophore Concept in Natural Product inspired Drug Design
por: Seidel, Thomas, et al.
Publicado: (2020)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

High expression of CIN85 promotes proliferation and invasion of human esophageal squamous cell carcinoma
por: Hua, Xiao-Yang, et al.
Publicado: (2021)

Cryptic binding sites on proteins: definition, detection, and druggability
por: Vajda, Sandor, et al.
Publicado: (2018)

CIN85 modulates TGFβ signaling by promoting the presentation of TGFβ receptors on the cell surface
por: Yakymovych, Ihor, et al.
Publicado: (2015)

SH3-Hunter: discovery of SH3 domain interaction sites in proteins
por: Ferraro, Enrico, et al.
Publicado: (2007)

The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85
por: Oellerich, Thomas, et al.
Publicado: (2011)

CIN85 drives B cell responses by linking BCR signals to the canonical NF-κB pathway
por: Kometani, Kohei, et al.
Publicado: (2011)

The Effect of Proline cis-trans Isomerization on the Folding of the C-Terminal SH2 Domain from p85
por: Troilo, Francesca, et al.
Publicado: (2019)

Spatiotemporal identification of druggable binding sites using deep learning
por: Kozlovskii, Igor, et al.
Publicado: (2020)

Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches
por: Darby, John F., et al.
Publicado: (2020)

A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS‐CoV‐2
por: Battisti, Verena, et al.
Publicado: (2020)

The applications of deep learning algorithms on in silico druggable proteins identification
por: Yu, Lezheng, et al.
Publicado: (2022)

Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein
por: Ghoula, M., et al.
Publicado: (2023)

The Drosophila CD2AP/CIN85 orthologue Cindr regulates junctions and cytoskeleton dynamics during tissue patterning
por: Johnson, Ruth I., et al.
Publicado: (2008)

E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK–CBL–CIN85 axis
por: Ahmed, Syed Feroj, et al.
Publicado: (2021)

Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
por: Vidler, Lewis R., et al.
Publicado: (2012)

Novel Roles of SH2 and SH3 Domains in Lipid Binding
por: Sipeki, Szabolcs, et al.
Publicado: (2021)

SH2 and SH3 domains
por: Pawson, Tony
Publicado: (1992)

The wages of CIN
por: Yuen, Karen W., et al.
Publicado: (2008)

Druggable Allosteric Sites in β‐Propeller Lectins
por: Shanina, Elena, et al.
Publicado: (2021)

The basic amino acids in the coiled-coil domain of CIN85 regulate its interaction with c-Cbl and phosphatidic acid during epidermal growth factor receptor (EGFR) endocytosis
por: Zheng, Xiudan, et al.
Publicado: (2014)

SH3 Domain Tyrosine Phosphorylation – Sites, Role and Evolution
por: Tatárová, Zuzana, et al.
Publicado: (2012)

In Silico Insights towards the Identification of NLRP3 Druggable Hot Spots
por: Mekni, Nedra, et al.
Publicado: (2019)

Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration
por: Cascio, Sandra, et al.
Publicado: (2013)

A Myristoyl-Binding Site in the SH3 Domain Modulates c-Src Membrane Anchoring
por: Le Roux, Anabel-Lise, et al.
Publicado: (2019)

Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space
por: Ziarek, Joshua J., et al.
Publicado: (2011)

ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma
por: Ma, Xiao-Lu, et al.
Publicado: (2023)

Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
por: Zhang, Xuxiao, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rdi6cqainpo6o0vrrf0ahvibp1